Correlation Between Israel Acquisitions and Opus Genetics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel Acquisitions and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel Acquisitions and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel Acquisitions Corp and Opus Genetics,, you can compare the effects of market volatilities on Israel Acquisitions and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel Acquisitions with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel Acquisitions and Opus Genetics,.

Diversification Opportunities for Israel Acquisitions and Opus Genetics,

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Israel and Opus is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Israel Acquisitions Corp and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Israel Acquisitions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel Acquisitions Corp are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Israel Acquisitions i.e., Israel Acquisitions and Opus Genetics, go up and down completely randomly.

Pair Corralation between Israel Acquisitions and Opus Genetics,

Given the investment horizon of 90 days Israel Acquisitions Corp is expected to generate 0.14 times more return on investment than Opus Genetics,. However, Israel Acquisitions Corp is 6.9 times less risky than Opus Genetics,. It trades about 0.08 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.13 per unit of risk. If you would invest  1,136  in Israel Acquisitions Corp on November 2, 2024 and sell it today you would earn a total of  13.00  from holding Israel Acquisitions Corp or generate 1.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Israel Acquisitions Corp  vs.  Opus Genetics,

 Performance 
       Timeline  
Israel Acquisitions Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Israel Acquisitions Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Israel Acquisitions is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Israel Acquisitions and Opus Genetics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel Acquisitions and Opus Genetics,

The main advantage of trading using opposite Israel Acquisitions and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel Acquisitions position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.
The idea behind Israel Acquisitions Corp and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings